Inhibitors of tyrosine kinase 2 mediated signaling
US-2020255423-A1 · Aug 13, 2020 · US
This page is not indexed by search engines while we improve data quality.
Van Epps Stacy A patents
Van Epps Stacy A is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Van Epps Stacy A |
| Total patents | 6 |
| First publication | Jan 1, 2015 |
| Latest publication | Aug 13, 2020 |
Notable patents
Publications ranked by popularity score, then publication date.
Inhibitors of tyrosine kinase 2 mediated signaling
US-10508113-B2 · Dec 17, 2019 · US
Inhibitors of tyrosine kinase 2 mediated signaling
US-2019276450-A1 · Sep 12, 2019 · US
Primary carboxamides as btk inhibitors
US-2017174624-A1 · Jun 22, 2017 · US
Primary carboxamides as BTK inhibitors
US-9567339-B2 · Feb 14, 2017 · US
Primary carboxamides as btk inhibitors
US-2015005279-A1 · Jan 1, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Abbvie Inc | 6 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D487/04 | 6 |
| C07D471/04 | 6 |
| A61K31/405 | 3 |
| C07D401/12 | 3 |
| C07D403/14 | 3 |